Acquisition of Zentiva by Advent
In September 2018, Advent acquired Zentiva from Sanofi for an enterprise value of €1,919 million.
Bucéphale Finance acted as financial advisor to Advent International in this transaction.
In September 2018, Advent acquired Zentiva from Sanofi for an enterprise value of €1,919 million.
Bucéphale Finance acted as financial advisor to Advent International in this transaction.